CURRENT ISSUE Current Issue Cover
VOL 5 • NUMBER 4 JUL/AUG
IN THIS ISSUE

Transparency in Medicare Reimbursement: Help or Hindrance?

Wendy H. Vogel, MSN, FNP, AOCNP®

Targeted Therapies in Breast Cancer: Implications for Advanced Oncology Practice

Laura Bourdeanu, PhD, and Thehan Luu, MD

The History and Physical in Cancer Care: A Primer for the Oncology Advanced Practitioner

Margaret Quinn Rosenzweig, PhD, FNP-BC, AOCNP®, Diane Gardner, FNP, MSN, and Brenda Griffith

Approaches to Managing Safety With Lenalidomide in Hematologic Malignancies

Susan Blumel, RN, BSN, and Jackie Broadway-Duren, DNP, APRN, FNP-C

More Articles More Articles
 
Section Seperator

TODAY'S NEWS

Study Helps Compare Risks of Endoscopic ...

A new study published in the <em>Journal of ...

Researchers Identify Irreversible Inhibi...

Researchers at UT Southwestern Medical Center...

Combination Afatinib and Cetuximab Yield...

A phase Ib study has found that a combination of t...

Promising Phase Ib Findings With Combine...

In a phase Ib study reported in <em>The Lanc...

Study Identifies Prevalence of Uterine M...

There is considerable concern that uterine morcell...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Management of Malignant Pericardial Effusion

The pericardium surrounds the heart...

The Case for Early Palliative Care in Ovarian Cancer

Once referred to as a silent killer...

Vismodegib for Basal Cell Carcinoma

Skin cancer is the most common cancer...

Healthy Weight Loss for the Cancer Survivor

For most oncology patients, weight gain is...

Lessons Learned in Cancer Care Communication

Over the past several decades, outcomes...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Failure to Adopt a Healthy Lifestyle Mor...

A St. Jude Children’s Research Hospital stud...

First Surveillance Imaging at 6 Months M...

Early surveillance imaging (< 6 months) after s...

FDA Expands Approved Use of Ibrutinib fo...

The U.S. Food and Drug Administration today expand...

Phase II Trial Supports Use of First-Lin...

As reported by Motzer et al in the <em>Journ...

Adding Induction Chemotherapy to Chemora...

In a phase III trial reported in the <em>Jou...

More Highlights More Highlights
 
Section Seperator
Section Seperator
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer